In vitro and in vivo Phlebovirus inhibition by ribavirin
about
In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus InfectionsEffect of ribavirin on subacute sclerosing panencephalitis virus infections in hamstersEfficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease modelsRecombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.Mechanism of La Crosse virus inhibition by ribavirin.Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay.Host genetic variation in susceptibility to Punta Toro virus.Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus.Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifs.Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.Potential role of immunomodulators for treatment of phlebovirus infections of animals.Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.
P2860
Q27481401-D9E3B830-28F3-481A-B8DA-25E0F0462CD4Q28369274-BA169406-1061-4C05-83A4-48BF2CDFBF66Q34432483-91CEA8FF-D94E-4017-8D18-F0DCA8AED39BQ34680603-979D9D23-98A1-4F5D-8A65-90D4D0971D59Q35361328-44F33294-724A-4547-9542-8AED19DB2288Q36462318-AF702BF9-0DBE-4F17-B5DD-DE46B9A13EE1Q36655849-CE55C5B2-97A0-4A44-B336-B930C858F7E2Q36754241-0B8A36F7-2D6C-4D06-BCF3-87E630E655E5Q37075232-8202B338-5190-4D8C-A156-D61FD1134EF7Q37439419-5F153D64-B29B-46B2-A837-E0BB5F791C28Q39467349-0395F086-8F9A-4162-A61C-8F39C9BA666FQ40732744-9E722987-4872-4408-A981-EF7F05C2F024Q43177533-51CFA614-4470-4534-B1FA-1A8FC3E420BFQ45324172-B6E7C07A-5F3F-41F7-91DE-EF2F7C7A7F29
P2860
In vitro and in vivo Phlebovirus inhibition by ribavirin
description
1988 nî lūn-bûn
@nan
1988 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մարտին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
In vitro and in vivo Phlebovirus inhibition by ribavirin
@ast
In vitro and in vivo Phlebovirus inhibition by ribavirin
@en
In vitro and in vivo Phlebovirus inhibition by ribavirin
@nl
type
label
In vitro and in vivo Phlebovirus inhibition by ribavirin
@ast
In vitro and in vivo Phlebovirus inhibition by ribavirin
@en
In vitro and in vivo Phlebovirus inhibition by ribavirin
@nl
prefLabel
In vitro and in vivo Phlebovirus inhibition by ribavirin
@ast
In vitro and in vivo Phlebovirus inhibition by ribavirin
@en
In vitro and in vivo Phlebovirus inhibition by ribavirin
@nl
P2093
P2860
P356
P1476
In vitro and in vivo Phlebovirus inhibition by ribavirin
@en
P2093
B B Barnett
J H Huffman
R W Sidwell
P2860
P356
10.1128/AAC.32.3.331
P407
P577
1988-03-01T00:00:00Z